C WorldWide Group Holding A S Has $1.78 Million Stock Position in Amdocs Limited (NASDAQ:DOX)

C WorldWide Group Holding A S decreased its stake in Amdocs Limited (NASDAQ:DOX) by 13.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 20,280 shares of the technology company’s stock after selling 3,268 shares during the period. C WorldWide Group Holding A S’s holdings in Amdocs were worth $1,782,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in DOX. Financiere des Professionnels Fonds d investissement inc. raised its holdings in Amdocs by 1.3% during the 4th quarter. Financiere des Professionnels Fonds d investissement inc. now owns 9,790 shares of the technology company’s stock valued at $860,000 after buying an additional 130 shares during the last quarter. First Eagle Investment Management LLC grew its position in shares of Amdocs by 6.3% in the 3rd quarter. First Eagle Investment Management LLC now owns 2,448 shares of the technology company’s stock worth $207,000 after buying an additional 145 shares during the period. CI Investments Inc. grew its position in shares of Amdocs by 0.7% in the 3rd quarter. CI Investments Inc. now owns 21,000 shares of the technology company’s stock worth $1,774,000 after buying an additional 152 shares during the period. Balentine LLC grew its position in Amdocs by 5.3% during the 3rd quarter. Balentine LLC now owns 3,050 shares of the technology company’s stock valued at $258,000 after purchasing an additional 153 shares during the last quarter. Finally, Wahed Invest LLC grew its position in Amdocs by 9.8% during the 3rd quarter. Wahed Invest LLC now owns 1,870 shares of the technology company’s stock valued at $158,000 after purchasing an additional 167 shares during the last quarter. Institutional investors own 92.02% of the company’s stock.

Amdocs Price Performance

DOX stock traded down $0.66 during midday trading on Friday, reaching $84.98. The stock had a trading volume of 575,911 shares, compared to its average volume of 493,415. Amdocs Limited has a 52-week low of $78.38 and a 52-week high of $99.75. The company has a market cap of $9.99 billion, a price-to-earnings ratio of 18.20, a price-to-earnings-growth ratio of 1.39 and a beta of 0.69. The company’s fifty day simple moving average is $89.62 and its 200 day simple moving average is $87.32. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.21.

Amdocs (NASDAQ:DOX) last released its earnings results on Tuesday, February 6th. The technology company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.16. The company had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.24 billion. Amdocs had a return on equity of 17.79% and a net margin of 11.30%. Amdocs’s revenue was up 5.0% compared to the same quarter last year. During the same period in the previous year, the company posted $1.33 EPS. As a group, sell-side analysts predict that Amdocs Limited will post 5.87 earnings per share for the current fiscal year.

Amdocs Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 26th. Investors of record on Friday, March 29th were issued a $0.479 dividend. This represents a $1.92 dividend on an annualized basis and a yield of 2.25%. This is an increase from Amdocs’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend was Wednesday, March 27th. Amdocs’s payout ratio is presently 41.11%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on DOX shares. Barclays raised their price target on shares of Amdocs from $105.00 to $115.00 and gave the company an “overweight” rating in a report on Thursday, February 8th. Citigroup raised their target price on shares of Amdocs from $96.00 to $104.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Finally, StockNews.com lowered shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Friday, March 15th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Amdocs has a consensus rating of “Buy” and an average price target of $108.60.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.